DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist NU Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns ORGO Q1 2026 Earnings Significant EPS Miss Raises Concerns ABXL Q1 2026 Earnings Modest EPS Miss Amid Stable Operations CACC Q1 2026 Earnings EPS Misses Estimates Slightly Stock Slips ATRA Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Progress Continues